| Literature DB >> 18305377 |
Masakiyo Hosokawa1, Tomomi Furihata, Yumiko Yaginuma, Naoko Yamamoto, Natsuko Watanabe, Eiko Tsukada, Yoshiko Ohhata, Kaoru Kobayashi, Testuo Satoh, Kan Chiba.
Abstract
Mammalian carboxylesterases comprise a multigene family, the gene products of which are localized in the endoplasmic reticulum. The carboxylesterases catalyze the hydrolysis of various xenobiotics and endogenous substrates such as ester, amide and thioester bonds and are thought to function mainly in drug metabolism. We have suggested the possibility that individual variation of human liver carboxylesterase activity causes the difference in expression levels of CES1A isozymes. However, little is known about the transcriptional regulation of human carboxylesterase genes. In the present study, we isolated two CES genes encoding human carboxylesterase CES1A, which were designated as CES1A1 (AB119997) and CES1A2 (AB119998). These genes were identical except for exon 1 and the 5' regulatory element. We investigated the transcriptional regulation of these two CES genes. A reporter gene assay and electrophoretic mobility shift assay demonstrated that Sp1 and C/EBPalpha could bind to each responsive element of the CES1A1 promoter but that the Sp1 and C/EBP could not bind to the responsive element of the CES1A2 promoter. Thus, CES1A1 mRNA expression level is much higher than the expression level of CES1A2 mRNA in the liver and lung. It is thought that these results provide information on individual variation of human carboxylesterase isozymes.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18305377 DOI: 10.2133/dmpk.23.73
Source DB: PubMed Journal: Drug Metab Pharmacokinet ISSN: 1347-4367 Impact factor: 3.614